Jay is joined by Dr. Jacque Duncan of the University of California San Francisco to discuss her research on quality of life improvements with the Argus II prosthesis and gene therapy, among other topics.
Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Alimera Science and Allergan. Dr. Duncan is a consultant for AGTC, Editas Medicine, ProQRTherapeutics, Spark Therapeutics and SparingVision. She receives grant support from Acucela, Allergan, Neurotech USA, NightstaRx Limited and Second Sight Medical Products. None of these disclosures had any bearing on the discussion.
Release: Feb. 21, 2019; expires Feb. 21, 2022
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.